# Tibet Aim Pharmaceuticals Techonology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tibet-aim-pharmaceuticals-techonology

- Industry: Pharmaceuticals
- Headquarters: Beijing, China
- Website: www.emyy.cn
- Total disclosed funding: $15M
- Latest round: Series A (Jun 1, 2014)
- Investors on record: 2

## About

Founded in 2004 and based in China, Tibet Aim Pharmaceuticals Techonology Ltd operates as a pharmaceutical manufacturer. In July 2012, the company acquired Sichuan Viao Pharmaceutical Co., Ltd. In June 2014, the firm raised CNY 80 million in series A funding. In December 2016, it was listed on the Shenzhen Stock Exchange. Its stock code is 002826. In 2022, the company invested in the migraine platform Love Health.

The company's main products include drugs for the endocrine system, cardiovascular and cerebrovascular systems, and rheumatology and orthopedics. It also provides rheumatology and orthopedics medications and digestive system medications.

The company’s revenue is generated by providing drugs.

## Funding rounds

- Series A, Jun 1, 2014, $13M — Golden China Fund, Beijing Haina Yourong Capital
- Seed, Mar 1, 2014, $1.6M — Golden China Fund

## Investors

- Golden China Fund (https://capitalatlas.ai/funds/golden-china-fund) — Seed, Series A
- Beijing Haina Yourong Capital (https://capitalatlas.ai/funds/beijing-haina-yourong-capital) — Series A